REQUEST A DEMO
Total
USD $0.00
Search more companies

Bestpharma Sp. z o.o. (Poland)

Main Activities: Chemical and Allied Products Merchant Wholesalers
Full name: Bestpharma Sp. z o.o. Profile Updated: September 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Bestpharma Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the Chemical and Allied Products Merchant Wholesalers industry. Bestpharma Sp. z o.o. was incorporated on December 31, 2015. There are currently 1 - 10 (2025) people employed by Bestpharma Sp. z o.o.. The latest financial highlights indicate a net sales revenue increase of 39.73% in 2025. Its’ total assets recorded a negative growth of 5.76%. The net profit margin of Bestpharma Sp. z o.o. increased by 2.76% in 2025.

Headquarters
Ul. Targowa 67/6A
Warsaw; Mazowieckie; Postal Code: 03-729

Contact Details: Purchase the Bestpharma Sp. z o.o. report to view the information.

Website: http://www.bestpharma.pl

Basic Information
Total Employees:
Purchase the Bestpharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bestpharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Bestpharma Sp. z o.o. report to view the information.
Incorporation Date:
December 31, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
82%
Company Performance
Financial values in the chart are available after Bestpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
39.73%
Total Operating Revenue
38.35%
Operating Profit
153.45%
EBITDA
147.74%
Net Profit/Loss for the Period
205.39%
Total Assets
-5.76%
Total Equity
103.45%
Operating Profit Margin
2.54%
Net Profit Margin
2.76%
Return on Equity (ROE)
16.97%
Debt / Equity
-93.48%
Quick Ratio
-0.11%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?